How much does Adcetris cost in the U.S.?
Pricing for Adcetris (brentuximab vedotin) can vary widely by insurer, the treatment regimen, dosing, and whether costs are billed under medical benefit vs. pharmacy benefit. Public, list-price-only comparisons often don’t reflect what patients actually pay.
To get a meaningful number, you typically need the drug’s cost for:
- the specific dose (mg) and schedule your clinician will use,
- your insurance coverage level (deductible, copay/coinsurance),
- your plan’s negotiated (contract) price, and
- any patient assistance programs.
What drives the out-of-pocket cost for patients?
Even when two people ask the same “Adcetris cost” question, the final out-of-pocket figure depends on factors like:
- Insurance type and coverage rules for oncology drugs
- Whether Adcetris is administered in an infusion center (often billed through medical channels)
- Copay/coinsurance and deductible status
- Prior authorization and diagnosis-specific coverage
- Duration of therapy (number of cycles)
How much does Adcetris cost per vial or per dose?
Adcetris is supplied in vial sizes and dosing is calculated from body weight, so “cost per dose” is not a fixed public number. If you tell me your body weight and the number of doses/cycles you’re expecting, I can help you translate that into a dose-based estimate you can then compare with billing or an insurance quote.
Are there cheaper alternatives or bios?
Adcetris is a brand-name antibody-drug conjugate. The availability of lower-cost alternatives depends on:
- whether a biosimilar/alternative ADC is approved for the same indication, and
- how insurers prefer to sequence therapies for that cancer type.
Can you reduce cost with assistance programs?
Many manufacturers and third-party programs offer assistance that can reduce:
- copays for commercially insured patients,
- costs for eligible uninsured/underinsured patients,
- and sometimes patient eligibility depends on diagnosis and income.
If you share whether you’re asking about list price, insurance cost, or patient out-of-pocket, and your country (and insurance status), I can narrow the answer to the most relevant cost perspective.